The finding "emphasizes the serious global health threat to pregnant
women and their infants posed by congenital (Zika virus) infection,"
said Dr. Margaret Honein of the Centers for Disease Control and
Prevention in Atlanta, writing in an editorial in the New England
Journal of Medicine, where the study appears.
The estimates do not include less-obvious developmental problems
that may surface later in life.
In addition, because the study only included women who fell ill,
they don't include the risk for women who may have been infected but
didn't experience symptoms, which happens in about 80 percent of
cases.
"Other studies showed earlier that the risk of births defects did
not depend on the presence or the severity of (Zika)-related
symptoms," chief author Dr. Bruno Hoen of the University Medical
Center of Guadeloupe told Reuters Health by email.
"This was really well done and it really does nail down the rate
that we're seeing in this population," said Dr. Carl Fichtenbaum, a
professor in the division of infectious diseases at the University
of Cincinnati College of Medicine in Ohio, who was not involved in
the research.
"The (birth defect) rate might differ in other populations,
depending on whether it's your first Zika infection or your second,"
he told Reuters Health by phone. "In populations where it's just
been introduced it might be more severe for the fetus, but I think
time will tell."
The 527 surviving babies in the new study will be followed for at
least two years.
"Only the longer-term follow-up of the children born to the women in
the current study will help identify the full spectrum of (Zika)-related
complications," the Hoen team said.
The virus was linked to birth defects, particularly having an
abnormally small head - a condition known as microcephaly - during a
2016-2017 outbreak. Zika vaccines are still being tested.
Estimates of the rate of congenital neurologic defects in infected
newborns have ranged from 6 percent to 42 percent. The Hoen team
included women who were pregnant from March through November of 2016
when it was confirmed that they had been infected with Zika.
[to top of second column] |
Their study of 555 fetuses and infants found evidence of
microcephaly in 5.8 percent. The rate of severe microcephaly was 1.6
percent.
The earlier the infection occurred in pregnancy, the greater the
risk.
Neurologic or eye problems were seen in 12.7 percent of the babies
whose mothers were infected during the first trimester. The rates
were 3.6 percent when mothers were infection during the second
trimester and 5.3 percent during the third.
This is "some of the most compelling data to date that the risk of
brain abnormalities, microcephaly, and eye anomalies extends to
infections in every trimester of pregnancy," said Honein in her
editorial.
The French territories were French Guiana, Guadeloupe and
Martinique.
A Zika registry in the United States has seen birth defects in 10
percent of women known to have been infected with the virus. When
the infection occurred during the first trimester, the rate has been
15 percent.
But those studies "do not provide information on the estimated 80
percent of pregnant women with (Zika) infections who have no
reported symptoms," Honein writes. "Population level increases in (Zika)-associated
birth defects are unlikely to be recognized without ongoing timely
and comprehensive surveillance of birth defects that captures all
affected fetuses and infants regardless of whether maternal (Zika)
exposure or infection was identified."
Zika "should definitely be added to the list of infectious agents
that can cause severe birth defects, as are rubella virus,
cytomegalovirus, and others," Hoen said in his email.
The study also emphasizes the urgent need to protect women who might
become pregnant when they are traveling or living in areas with Zika-infected
mosquitoes, to test women at risk for Zika when they become
pregnant, and to develop an effective vaccine, he said.
SOURCE: http://bit.ly/2pbtgq2 The New England Journal of Medicine,
online March 14, 2018.
[© 2018 Thomson Reuters. All rights
reserved.] Copyright 2018 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |